1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Samsara BioCapital, LLC Buys Principia Biopharma Inc, Rhythm Pharmaceuticals Inc, Aimmune Therapeutics Inc

Investment company Samsara BioCapital, LLC (Current Portfolio) buys Principia Biopharma Inc, Rhythm Pharmaceuticals Inc, Aimmune Therapeutics Inc, Aclaris Therapeutics Inc, Pieris Pharmaceuticals Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Samsara BioCapital, LLC. As of 2020Q1, Samsara BioCapital, LLC owns 26 stocks with a total value of $160 million. These are the details of the buys and sells.

For the details of Samsara BioCapital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/samsara+biocapital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Samsara BioCapital, LLC
  1. Intercept Pharmaceuticals Inc (ICPT) - 403,688 shares, 15.93% of the total portfolio.
  2. Principia Biopharma Inc (PRNB) - 401,046 shares, 14.93% of the total portfolio. Shares added by 30.73%
  3. SpringWorks Therapeutics Inc (SWTX) - 625,281 shares, 10.58% of the total portfolio. Shares reduced by 4.32%
  4. Odonate Therapeutics Inc (ODT) - 522,637 shares, 9.05% of the total portfolio.
  5. Allakos Inc (ALLK) - 270,965 shares, 7.56% of the total portfolio. Shares added by 11.74%
New Purchase: Rhythm Pharmaceuticals Inc (RYTM)

Samsara BioCapital, LLC initiated holding in Rhythm Pharmaceuticals Inc. The purchase prices were between $13.16 and $22.96, with an estimated average price of $18.01. The stock is now traded at around $18.51. The impact to a portfolio due to this purchase was 2.64%. The holding were 276,289 shares as of .

New Purchase: Aimmune Therapeutics Inc (AIMT)

Samsara BioCapital, LLC initiated holding in Aimmune Therapeutics Inc. The purchase prices were between $11.48 and $36.56, with an estimated average price of $25.86. The stock is now traded at around $16.34. The impact to a portfolio due to this purchase was 2.1%. The holding were 232,571 shares as of .

New Purchase: Aclaris Therapeutics Inc (ACRS)

Samsara BioCapital, LLC initiated holding in Aclaris Therapeutics Inc. The purchase prices were between $0.75 and $2.18, with an estimated average price of $1.38. The stock is now traded at around $1.29. The impact to a portfolio due to this purchase was 1.7%. The holding were 2,608,117 shares as of .

New Purchase: Rocket Pharmaceuticals Inc (RCKT)

Samsara BioCapital, LLC initiated holding in Rocket Pharmaceuticals Inc. The purchase prices were between $9.71 and $25.11, with an estimated average price of $19.93. The stock is now traded at around $19.84. The impact to a portfolio due to this purchase was 1.12%. The holding were 128,197 shares as of .

New Purchase: Portola Pharmaceuticals Inc (PTLA)

Samsara BioCapital, LLC initiated holding in Portola Pharmaceuticals Inc. The purchase prices were between $5.78 and $24.74, with an estimated average price of $12.7. The stock is now traded at around $17.82. The impact to a portfolio due to this purchase was 0.71%. The holding were 159,772 shares as of .

New Purchase: bluebird bio Inc (BLUE)

Samsara BioCapital, LLC initiated holding in bluebird bio Inc. The purchase prices were between $40.39 and $98.04, with an estimated average price of $75.99. The stock is now traded at around $56.66. The impact to a portfolio due to this purchase was 0.71%. The holding were 24,790 shares as of .

Added: Principia Biopharma Inc (PRNB)

Samsara BioCapital, LLC added to a holding in Principia Biopharma Inc by 30.73%. The purchase prices were between $43.5 and $74.09, with an estimated average price of $58.41. The stock is now traded at around $64.11. The impact to a portfolio due to this purchase was 3.51%. The holding were 401,046 shares as of .

Added: Pieris Pharmaceuticals Inc (PIRS)

Samsara BioCapital, LLC added to a holding in Pieris Pharmaceuticals Inc by 130.08%. The purchase prices were between $1.61 and $4.24, with an estimated average price of $3.17. The stock is now traded at around $2.72. The impact to a portfolio due to this purchase was 1.31%. The holding were 1,620,249 shares as of .

Added: IVERIC bio Inc (ISEE)

Samsara BioCapital, LLC added to a holding in IVERIC bio Inc by 23.22%. The purchase prices were between $2.83 and $8.58, with an estimated average price of $5.91. The stock is now traded at around $3.69. The impact to a portfolio due to this purchase was 0.35%. The holding were 862,552 shares as of .

Added: KalVista Pharmaceuticals Inc (KALV)

Samsara BioCapital, LLC added to a holding in KalVista Pharmaceuticals Inc by 41.92%. The purchase prices were between $5.8 and $18.56, with an estimated average price of $13.66. The stock is now traded at around $10.15. The impact to a portfolio due to this purchase was 0.24%. The holding were 168,174 shares as of .



Here is the complete portfolio of Samsara BioCapital, LLC. Also check out:

1. Samsara BioCapital, LLC's Undervalued Stocks
2. Samsara BioCapital, LLC's Top Growth Companies, and
3. Samsara BioCapital, LLC's High Yield stocks
4. Stocks that Samsara BioCapital, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)